Evidence map›Paper›PMID 27877129›Full record

ArticleFrontiers in pharmacology2016

Curcumin Inhibits Transforming Growth Factor β Induced Differentiation of Mouse Lung Fibroblasts to Myofibroblasts.

Daishun Liu, Ling Gong, Honglan Zhu, Shenglan Pu, Yang Wu, Wei Zhang, Guichuan Huang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Curcumin in Fibrosis Treatment: A Review.Drug design, development and therapy · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Daishun LiuDepartment of Respiratory Medicine, Institute of Respiratory Diseases in Zunyi, The First People's Hospital of Zunyi, The Third Affiliated Hospital of Zunyi Medical College Zunyi, China.
Ling GongDepartment of Respiratory Medicine, Institute of Respiratory Diseases in Zunyi, The First People's Hospital of Zunyi, The Third Affiliated Hospital of Zunyi Medical College Zunyi, China.
Honglan ZhuDepartment of Respiratory Medicine, Institute of Respiratory Diseases in Zunyi, The First People's Hospital of Zunyi, The Third Affiliated Hospital of Zunyi Medical College Zunyi, China.
Shenglan PuDepartment of Respiratory Medicine, Institute of Respiratory Diseases in Zunyi, The First People's Hospital of Zunyi, The Third Affiliated Hospital of Zunyi Medical College Zunyi, China.
Yang WuDepartment of Respiratory Medicine, Institute of Respiratory Diseases in Zunyi, The First People's Hospital of Zunyi, The Third Affiliated Hospital of Zunyi Medical College Zunyi, China.
Wei ZhangDepartment of Respiratory Medicine, Institute of Respiratory Diseases in Zunyi, The First People's Hospital of Zunyi, The Third Affiliated Hospital of Zunyi Medical College Zunyi, China.
Guichuan HuangDepartment of Respiratory Medicine, Institute of Respiratory Diseases in Zunyi, The First People's Hospital of Zunyi, The Third Affiliated Hospital of Zunyi Medical College Zunyi, China.
First People’s Hospital of Zunyi · CNAffiliated Hospital of Zunyi Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transforming growth factor β (TGF-β) induced differentiation of lung fibroblasts to myofibroblasts is a key event in the pathogenesis of pulmonary fibrosis. This study aimed to evaluate the effect of curcumin on TGF-β induced differentiation of lung fibroblasts to myofibroblasts and explore the underlying mechanism. Mouse lung fibroblasts were cultured and treated with TGF-β2 and curcumin or rosiglitazone. Cell vitality was examined by MTT assay. The secretion of collagen-1 was assessed by ELISA. α smooth muscle actin (α-SMA) was visualized by immunofluorescence technique. The expression of peroxisome proliferator activated receptor γ (PPAR-γ) and platelet derived growth factor R β (PDGFR-β) was detected by PCR and Western blot analysis. We found that curcumin and rosiglitazone inhibited the proliferation and TGF-β induced differentiation of mouse lung fibroblasts. In addition, curcumin and rosiglitazone inhibited collagen-1 secretion and α-SMA expression in mouse lung fibroblasts. Furthermore, curcumin and rosiglitazone upregulated PPAR-γ and downregulated PDGFR-β expression in mouse lung fibroblasts. In conclusion, our study reveals novel mechanism by which curcumin inhibits TGF-β2 driven differentiation of lung fibroblasts to myofibroblasts. Curcumin could potentially be used for effective treatment of pulmonary fibrosis.

Indexed as

curcuminperoxisome proliferator activated receptor γplatelet derived growth factor receptor βpulmonary fibrosistransforming growth factor β2

Identifiers

PMID27877129
PMCPMC5099146
OpenAlexW2550171864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.